PERSIS HEALTH INNOVATION LTD

Company Registration Number:
15981486 (England and Wales)

Unaudited statutory accounts for the year ended 30 September 2025

Period of accounts

Start date: 26 September 2024

End date: 30 September 2025

PERSIS HEALTH INNOVATION LTD

Contents of the Financial Statements

for the Period Ended 30 September 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

PERSIS HEALTH INNOVATION LTD

Directors' report period ended 30 September 2025

The directors present their report with the financial statements of the company for the period ended 30 September 2025

Principal activities of the company

The principal activity of the company during the period was research and experimental development in natural sciences and engineering. During the period, the director engaged in fundraising activities, including attending investor conferences, workshops and networking events, and submitting grant applications through UKRI. The company is in its pre-revenue stage and no external investment or grant funding has been received to date.



Directors

The director shown below has held office during the whole of the period from
26 September 2024 to 30 September 2025

Poyan Joodatnia


Secretary Ghazal Hatami Fard

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
13 May 2026

And signed on behalf of the board by:
Name: Poyan Joodatnia
Status: Director

PERSIS HEALTH INNOVATION LTD

Profit And Loss Account

for the Period Ended 30 September 2025

2025


£
Turnover: 0
Cost of sales: 0
Gross profit(or loss): 0
Distribution costs: 0
Administrative expenses: ( 3,836 )
Other operating income: 0
Operating profit(or loss): (3,836)
Interest receivable and similar income: 0
Profit(or loss) before tax: (3,836)
Profit(or loss) for the financial year: (3,836)

PERSIS HEALTH INNOVATION LTD

Balance sheet

As at 30 September 2025

Notes 2025


£
Called up share capital not paid: 100
Fixed assets
Intangible assets:   0
Tangible assets:   0
Investments:   0
Total fixed assets: 0
Current assets
Stocks:   0
Debtors:   0
Cash at bank and in hand: 0
Investments:   0
Total current assets: 0
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: 3 ( 3,836 )
Net current assets (liabilities): (3,836)
Total assets less current liabilities: (3,736)
Accruals and deferred income: 0
Total net assets (liabilities): (3,736)
Capital and reserves
Called up share capital: 100
Share premium account: 0
Other reserves: 0
Profit and loss account: (3,836 )
Total Shareholders' funds: ( 3,736 )

The notes form part of these financial statements

PERSIS HEALTH INNOVATION LTD

Balance sheet statements

For the year ending 30 September 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 13 May 2026
and signed on behalf of the board by:

Name: Poyan Joodatnia
Status: Director

The notes form part of these financial statements

PERSIS HEALTH INNOVATION LTD

Notes to the Financial Statements

for the Period Ended 30 September 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover represents the value of goods and services provided to customers during the accounting period, excluding value added tax. The company is in its pre-revenue stage and no turnover was generated during the period ended September 2025.

PERSIS HEALTH INNOVATION LTD

Notes to the Financial Statements

for the Period Ended 30 September 2025

  • 2. Employees

    2025
    Average number of employees during the period 0

PERSIS HEALTH INNOVATION LTD

Notes to the Financial Statements

for the Period Ended 30 September 2025

3. Creditors: amounts falling due within one year note

2025
£
Other creditors 3,836
Total 3,836